[Should adjuvant or neoadjuvant treatment be administered in esophageal cancer?].
This paper is dedicated to adjuvant treatments in surgery for esophageal squamous cell carcinoma. Randomized studies of neo-adjuvant or adjuvant radiotherapy, chemotherapy or radio-chemotherapy are considered. No trial has yet demonstrated the efficacy of a treatment complementary to surgery. Clinical research must be persued, testing the most effective therapies in non-operable cancers of the esophagus, especially "up-to-date" radio-chemotherapy.